Annual CFI
$36.20 M
-$1.95 M-5.12%
31 December 2023
Summary:
Cardiff Oncology annual cash flow from investing activities is currently $36.20 million, with the most recent change of -$1.95 million (-5.12%) on 31 December 2023. During the last 3 years, it has risen by +$36.41 million (+17254.03%). CRDF annual CFI is now -5.12% below its all-time high of $38.15 million, reached on 31 December 2022.CRDF Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$9.43 M
-$23.45 M-167.31%
30 September 2024
Summary:
Cardiff Oncology quarterly cash flow from investing activities is currently -$9.43 million, with the most recent change of -$23.45 million (-167.31%) on 30 September 2024. Over the past year, it has dropped by -$13.26 million (-346.90%). CRDF quarterly CFI is now -150.03% below its all-time high of $18.86 million, reached on 30 June 2017.CRDF Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$22.78 M
-$13.26 M-36.79%
30 September 2024
Summary:
Cardiff Oncology TTM cash flow from investing activities is currently $22.78 million, with the most recent change of -$13.26 million (-36.79%) on 30 September 2024. Over the past year, it has dropped by -$6.88 million (-23.19%). CRDF TTM CFI is now -40.29% below its all-time high of $38.15 million, reached on 31 December 2022.CRDF TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.1% | -346.9% | -23.2% |
| 3 y3 years | +10000.0% | -217.2% | +118.6% |
| 5 y5 years | +10000.0% | -10000.0% | +10000.0% |
CRDF Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.1% | +127.5% | -151.4% | at low | -40.3% | +117.3% |
| 5 y | 5 years | -5.1% | +127.5% | -151.4% | +91.5% | -40.3% | +117.3% |
| alltime | all time | -5.1% | +127.5% | -150.0% | +91.5% | -40.3% | +117.3% |
Cardiff Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.43 M(-167.3%) | $22.78 M(-36.8%) |
| June 2024 | - | $14.02 M(+202.3%) | $36.03 M(+7.6%) |
| Mar 2024 | - | $4.64 M(-65.8%) | $33.50 M(-7.4%) |
| Dec 2023 | $36.20 M(-5.1%) | $13.56 M(+254.9%) | $36.20 M(+22.1%) |
| Sept 2023 | - | $3.82 M(-66.7%) | $29.65 M(-4.3%) |
| June 2023 | - | $11.48 M(+56.7%) | $31.00 M(+14.3%) |
| Mar 2023 | - | $7.33 M(+4.4%) | $27.12 M(-28.9%) |
| Dec 2022 | $38.15 M(-129.0%) | $7.02 M(+36.0%) | $38.15 M(+70.8%) |
| Sept 2022 | - | $5.16 M(-32.1%) | $22.34 M(-11.4%) |
| June 2022 | - | $7.61 M(-58.6%) | $25.22 M(-1911.9%) |
| Mar 2022 | - | $18.36 M(-308.8%) | -$1.39 M(-98.9%) |
| Dec 2021 | -$131.45 M(>+9900.0%) | -$8.79 M(-209.3%) | -$131.45 M(+7.1%) |
| Sept 2021 | - | $8.05 M(-142.4%) | -$122.71 M(-6.3%) |
| June 2021 | - | -$19.00 M(-83.0%) | -$130.91 M(+17.0%) |
| Mar 2021 | - | -$111.70 M(>+9900.0%) | -$111.91 M(>+9900.0%) |
| Dec 2020 | -$211.00 K(+212.1%) | -$57.00 K(-63.0%) | -$211.00 K(+37.0%) |
| Sept 2020 | - | -$154.00 K(<-9900.0%) | -$154.00 K(+147.2%) |
| June 2020 | - | $0.00(0.0%) | -$62.30 K(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | -$62.30 K(-7.8%) |
| Dec 2019 | -$67.60 K(-396.5%) | $0.00(-100.0%) | -$67.60 K(0.0%) |
| Sept 2019 | - | -$62.30 K(<-9900.0%) | -$67.60 K(-225.0%) |
| June 2019 | - | $0.00(-100.0%) | $54.10 K(+139.4%) |
| Mar 2019 | - | -$5300.00(<-9900.0%) | $22.60 K(-0.9%) |
| Dec 2018 | $22.80 K(-99.9%) | $0.00(-100.0%) | $22.80 K(-61.7%) |
| Sept 2018 | - | $59.40 K(-288.6%) | $59.50 K(-151.6%) |
| June 2018 | - | -$31.50 K(+517.6%) | -$115.40 K(-100.6%) |
| Mar 2018 | - | -$5100.00(-113.9%) | $18.77 M(-21.7%) |
| Dec 2017 | $23.96 M | $36.70 K(-131.8%) | $23.96 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$115.50 K(-100.6%) | $24.34 M(-12.5%) |
| June 2017 | - | $18.86 M(+263.8%) | $27.83 M(-244.2%) |
| Mar 2017 | - | $5.18 M(+1147.0%) | -$19.30 M(-22.3%) |
| Dec 2016 | -$24.83 M(+1011.9%) | $415.70 K(-87.7%) | -$24.83 M(-5.3%) |
| Sept 2016 | - | $3.37 M(-111.9%) | -$26.23 M(-13.1%) |
| June 2016 | - | -$28.27 M(+7931.4%) | -$30.17 M(+1190.1%) |
| Mar 2016 | - | -$352.00 K(-64.0%) | -$2.34 M(+4.7%) |
| Dec 2015 | -$2.23 M(+645.0%) | -$976.50 K(+71.6%) | -$2.23 M(+69.1%) |
| Sept 2015 | - | -$569.00 K(+29.1%) | -$1.32 M(+54.7%) |
| June 2015 | - | -$440.90 K(+78.4%) | -$854.20 K(+99.3%) |
| Mar 2015 | - | -$247.10 K(+284.9%) | -$428.50 K(+42.9%) |
| Dec 2014 | -$299.80 K(-53.8%) | -$64.20 K(-37.1%) | -$299.90 K(-4.5%) |
| Sept 2014 | - | -$102.00 K(+571.1%) | -$313.90 K(-25.8%) |
| June 2014 | - | -$15.20 K(-87.2%) | -$422.90 K(-37.3%) |
| Mar 2014 | - | -$118.50 K(+51.5%) | -$674.50 K(+3.9%) |
| Dec 2013 | -$649.30 K(+140.4%) | -$78.20 K(-62.9%) | -$649.40 K(+3.2%) |
| Sept 2013 | - | -$211.00 K(-20.9%) | -$629.10 K(+28.5%) |
| June 2013 | - | -$266.80 K(+185.7%) | -$489.40 K(+84.3%) |
| Mar 2013 | - | -$93.40 K(+61.3%) | -$265.60 K(-1.7%) |
| Dec 2012 | -$270.10 K(>+9900.0%) | -$57.90 K(-18.8%) | -$270.20 K(+27.3%) |
| Sept 2012 | - | -$71.30 K(+65.8%) | -$212.30 K(+50.6%) |
| June 2012 | - | -$43.00 K(-56.1%) | -$141.00 K(+43.9%) |
| Mar 2012 | - | -$98.00 K(<-9900.0%) | -$98.00 K(+6433.3%) |
| Dec 2011 | -$1500.00(-98.9%) | $0.00(0.0%) | -$1500.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | -$1500.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) | -$1500.00(0.0%) |
| Mar 2011 | - | -$1500.00 | -$1500.00 |
| Dec 2010 | -$132.40 K | - | - |
FAQ
- What is Cardiff Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Cardiff Oncology?
- What is Cardiff Oncology annual CFI year-on-year change?
- What is Cardiff Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cardiff Oncology?
- What is Cardiff Oncology quarterly CFI year-on-year change?
- What is Cardiff Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cardiff Oncology?
- What is Cardiff Oncology TTM CFI year-on-year change?
What is Cardiff Oncology annual cash flow from investing activities?
The current annual CFI of CRDF is $36.20 M
What is the all time high annual CFI for Cardiff Oncology?
Cardiff Oncology all-time high annual cash flow from investing activities is $38.15 M
What is Cardiff Oncology annual CFI year-on-year change?
Over the past year, CRDF annual cash flow from investing activities has changed by -$1.95 M (-5.12%)
What is Cardiff Oncology quarterly cash flow from investing activities?
The current quarterly CFI of CRDF is -$9.43 M
What is the all time high quarterly CFI for Cardiff Oncology?
Cardiff Oncology all-time high quarterly cash flow from investing activities is $18.86 M
What is Cardiff Oncology quarterly CFI year-on-year change?
Over the past year, CRDF quarterly cash flow from investing activities has changed by -$13.26 M (-346.90%)
What is Cardiff Oncology TTM cash flow from investing activities?
The current TTM CFI of CRDF is $22.78 M
What is the all time high TTM CFI for Cardiff Oncology?
Cardiff Oncology all-time high TTM cash flow from investing activities is $38.15 M
What is Cardiff Oncology TTM CFI year-on-year change?
Over the past year, CRDF TTM cash flow from investing activities has changed by -$6.88 M (-23.19%)